<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04996329</url>
  </required_header>
  <id_info>
    <org_study_id>2017YFC2019-255</org_study_id>
    <nct_id>NCT04996329</nct_id>
  </id_info>
  <brief_title>Early Health Warning Intervention in Tobacco Control</brief_title>
  <official_title>A Comprehensive Tobacco Control With Early Health Warning Intervention in High Risk Population of COPD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University First Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Second Hospital of Hebei Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Henan Provincial People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Second Hospital of Jilin University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital Xi'an Jiaotong University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shandong Provincial Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanxi Bethune Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tianjin Medical University General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Affiliated Hospital of Inner Mongolia Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Hospital of Qinhuangdao</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Peking University First Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multi-center, randomized, controlled intervention clinical trial. A total of 1000&#xD;
      current smokers with rapid decline in lung function will be recruited and equally divided&#xD;
      into two groups, comprehensive smoking cessation intervention group (early health warning&#xD;
      intervention combined with brief smoking cessation intervention) and brief smoking cessation&#xD;
      intervention group. It is aimed to evaluate whether early health warning intervention will&#xD;
      increase the rate of smoking cessation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multi-center, randomized, controlled intervention clinical trial. A total of 1,000&#xD;
      current smokers ( ≥ 10 pack-years) with rapid decline in lung function will be recruited from&#xD;
      Predictive Value of Inflammatory Biomarkers and FEV1 for COPD (PIFCOPD) study (clinical&#xD;
      trails. gov ID NCT03532893) after 1 year of follow-up. Subjects will be qually divided into&#xD;
      two groups, comprehensive smoking cessation intervention group (early health warning&#xD;
      intervention combined with brief smoking cessation intervention) and brief smoking cessation&#xD;
      intervention group. Health warning intervention is to tell the subjects that smoking leads to&#xD;
      the rapid decline of their lung function, and they are at the high risk of developing COPD.&#xD;
      The Department of Respiratory and Critical Care of Peking University First Hospital is&#xD;
      responsible for this research. Other 9 units participating in the study, include the The&#xD;
      Second Hospital of Hebei Medical University, Henan Provincial People's Hospital, The Second&#xD;
      Hospital of Jilin University, The First Affiliated Hospital of Xi'an Jiaotong University,&#xD;
      Shandong Provincial Hospital Affiliated to Shandong University, Shan xi Dayi Hospital（Shanxi&#xD;
      Academy of Medical Sciences）, Tianjin Medical University General Hospital, The Affiliated&#xD;
      Hospital of Inner Mongolia University. Some questionnaire about tobacco dependence,&#xD;
      depression, anxiety, the willingness to quit smoking and withdrawal symptoms will be&#xD;
      collected. Exhaled CO will be measured. Subjects will recived 6 times of smoking cessation&#xD;
      intervention in 6 month and followed in another 6 month. The primary outcome is the rate of&#xD;
      quitting smoking. The study protocol has been approved by the Peking University First&#xD;
      Hospital Institutional Review Board (IRB) (2019-255). Any protocol modifications will be&#xD;
      submitted for the IRB review and approval.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 21, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>rate of quitting smoking</measure>
    <time_frame>1 year</time_frame>
    <description>keep smoking cessation for more than 6 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>one month smoking cessation rate</measure>
    <time_frame>6 months</time_frame>
    <description>stop smoking for more than one month, but less than six months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>smoking reduction rate</measure>
    <time_frame>1 year</time_frame>
    <description>less than the number of cigarettes before the first intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>smoking cessation rate at each follow-up</measure>
    <time_frame>6 months</time_frame>
    <description>stop smoking for 24 hours or more</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>relapse rate</measure>
    <time_frame>1 year</time_frame>
    <description>relapse rate of smoking</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Smoking Cessation</condition>
  <arm_group>
    <arm_group_label>comprehensive smoking cessation intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Early health warning intervention combined with brief smoking cessation intervention Early health warning intervention is to tell the subjects that smoking leads to the rapid decline of their lung function, and they are at the high risk of developing COPD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>brief smoking cessation intervention group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>brief smoking cessation intervention only</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>early health warning intervention</intervention_name>
    <description>early health warning intervention is to tell the subjects that smoking leads to the rapid decline of their lung function, and they are at the high risk of developing COPD.</description>
    <arm_group_label>brief smoking cessation intervention group</arm_group_label>
    <arm_group_label>comprehensive smoking cessation intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. aged at 40-75 years old;&#xD;
&#xD;
          2. FEV1/FVC&gt;70% after inhaled bronchodilator&#xD;
&#xD;
          3. current smoker (≥ 10 pack-years)&#xD;
&#xD;
          4. rate of FEV1 decline &gt;30ml/y&#xD;
&#xD;
          5. lived in a community for more than 1 years and has no plans to move out in the next 4&#xD;
             years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. history of asthma, COPD, lung cancer, active pulmonary tuberculosis, bronchiectasis,&#xD;
             diffuse lung disease (interstitial pneumonia, pulmonary sarcoidosis, occupational lung&#xD;
             disease, sarcoidosis et al) and pleural disease;&#xD;
&#xD;
          2. history of lobectomy and / or lung transplantation;&#xD;
&#xD;
          3. predicted life expectancy less than 3 years;&#xD;
&#xD;
          4. history of severe psychiatric illnesses, mental disorders, neurological disorders,&#xD;
             malignant tumors, chronic liver disease, heart failure, autoimmune diseases, chronic&#xD;
             kidney disease;&#xD;
&#xD;
          5. Alcoholism, drug abuse or abuse of toxic solvents;&#xD;
&#xD;
          6. Cannot finish long term follow-up or poor compliance;&#xD;
&#xD;
          7. Do not provide consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Guangfa Wang, MD</last_name>
    <phone>+86 13810644029</phone>
    <email>wangguangfa@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jiping Liao, MD</last_name>
    <phone>+86 13521714181</phone>
    <email>jipingliao@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Peking University First Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiping Liao, MD</last_name>
      <phone>+86 13521714181</phone>
      <email>jipingliao@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Second Hospital of Jilin University</name>
      <address>
        <city>Ch'ang-ch'un</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jinzhi Ying, MD</last_name>
      <email>yjz6437@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Affiliated Hospital of Inner Mongolia Medical University</name>
      <address>
        <city>Hohhot</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiuhua Fu, MD</last_name>
      <email>fuxiuhua555@sohu.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shandong Provincial Hospital Affiliated to Shandong University</name>
      <address>
        <city>Jing'an</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jian Sun, MD</last_name>
      <email>docbenjaminsun@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Hospital of Qinhuangdao</name>
      <address>
        <city>Qinhuangdao</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hua Qiao, MD</last_name>
      <email>qh1202@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Second Hospital of Hebei Medical University</name>
      <address>
        <city>Shijia Zhuang</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xixin Yan, MD</last_name>
      <phone>+86 15803210959</phone>
      <email>xi_xin_yan@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shanxi Bethune Hospital</name>
      <address>
        <city>Taiyuan</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruiying Wang, MD</last_name>
      <phone>+86 13903436432</phone>
      <email>wry0526@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tianjin Medical University General Hospital</name>
      <address>
        <city>Tianjin</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lixia Dong, MD</last_name>
      <email>luckydonglixia@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Xi'an Jiaotong University</name>
      <address>
        <city>Xi'an</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaomin Dang, MD</last_name>
      <email>dxming112@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Henan Provincial People's Hospita</name>
      <address>
        <city>Zhenzhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Limin Zhao, MD</last_name>
      <email>zlm9898@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>August 2, 2021</study_first_submitted>
  <study_first_submitted_qc>August 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2021</study_first_posted>
  <last_update_submitted>August 2, 2021</last_update_submitted>
  <last_update_submitted_qc>August 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>smoking cessation</keyword>
  <keyword>brief smoking cessation intervention</keyword>
  <keyword>current smokers</keyword>
  <keyword>rapid decline in lung function</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

